NASDAQ:ABDC - Alcentra Capital Stock Price, News & Analysis

Alcentra Capital trades on the NASDAQ under the ticker symbol "ABDC."

Alcentra Capital announced a quarterly dividend on Monday, August 5th. Shareholders of record on Thursday, September 26th will be paid a dividend of $0.18 per share on Thursday, October 3rd. This represents a $0.72 dividend on an annualized basis and a yield of 8.10%. The ex-dividend date of this dividend is Wednesday, September 25th. View Alcentra Capital's Dividend History.

Alcentra Capital declared that its Board of Directors has authorized a stock buyback program on Friday, November 17th 2017, which permits the company to repurchase $2,500,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company's management believes its stock is undervalued.

Alcentra Capital Corp (NASDAQ:ABDC) issued its quarterly earnings results on Wednesday, August, 7th. The asset manager reported $0.20 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.20 by $0.00. The asset manager had revenue of $6.14 million for the quarter, compared to the consensus estimate of $6.11 million. Alcentra Capital had a return on equity of 8.30% and a net margin of 31.91%. View Alcentra Capital's Earnings History.

Alcentra Capital is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Alcentra Capital.

News headlines about ABDC stock have trended negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Alcentra Capital earned a coverage optimism score of -2.3 on InfoTrie's scale. They also assigned news coverage about the asset manager a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Alcentra Capital.

Alcentra Capital saw a decline in short interest in July. As of July 31st, there was short interest totalling 15,900 shares, a decline of 32.6% from the June 30th total of 23,600 shares. Based on an average trading volume of 26,100 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.1% of the company's shares are short sold. View Alcentra Capital's Current Options Chain.

Some companies that are related to Alcentra Capital include Diamond Hill Investment Group (DHIL), Fidus Investment (FDUS), Westwood Holdings Group (WHG), Value Line (VALU), Saratoga Investment (SAR), Monroe Capital (MRCC), Silvercrest Asset Management Group (SAMG), StoneCastle Financial (BANX), Great Elm Capital (GECC), Fifth Street Asset Management (FSAM), Hennessy Advisors (HNNA), U.S. Global Investors (GROW), Puhui Wealth Investment Managemnt (PHCF), Manning and Napier (MN) and Medley Management (MDLY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcentra Capital investors own include Energy Transfer LP Unit (ET), SunCoke Energy Partners (SXCP), THL Credit (TCRD), Cornerstone Total Return Fund (CRF), Garrison Capital (GARS), Arlington Asset Investment (AI), Capitala Finance (CPTA), CBL & Associates Properties (CBL), NGL Energy Partners (NGL) and SandRidge Permian Trust (PER).

Alcentra Capital's stock is owned by a number of of retail and institutional investors. Top institutional investors include Bank of New York Mellon Corp (5.25%), Pacific Ridge Capital Partners LLC (3.55%), Morgan Stanley (3.41%), Oppenheimer & Co. Inc. (0.22%), Acadian Asset Management LLC (0.13%) and Appleton Partners Inc. MA (0.08%). Company insiders that own Alcentra Capital stock include Branko Krmpotic, David Scopelliti, Douglas J /Ma Greenlaw, Edward Grebow, Ellida Mcmillan, Paul J Echausse, Steven H Reiff, Suhail A Shaikh and T Ulrich Brechbuhl. View Institutional Ownership Trends for Alcentra Capital.

ABDC stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp and Oppenheimer & Co. Inc.. View Insider Buying and Selling for Alcentra Capital.

ABDC stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Pacific Ridge Capital Partners LLC, Appleton Partners Inc. MA and Acadian Asset Management LLC. Company insiders that have bought Alcentra Capital stock in the last two years include Branko Krmpotic, David Scopelliti, Douglas J /Ma Greenlaw, Edward Grebow, Ellida Mcmillan, Steven H Reiff, Suhail A Shaikh and T Ulrich Brechbuhl. View Insider Buying and Selling for Alcentra Capital.

Shares of ABDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ABDC stock can currently be purchased for approximately $8.89.

Alcentra Capital has a market capitalization of $114.47 million and generates $28.97 million in revenue each year. The asset manager earns $5.52 million in net income (profit) each year or $1.01 on an earnings per share basis. View Additional Information About Alcentra Capital.

The official website for Alcentra Capital is http://www.alcentracapital.com/.

Alcentra Capital's mailing address is 200 PARK AVENUE 7TH FLOOR, NEW YORK NY, 10166. The asset manager can be reached via phone at 212-922-8240 or via email at [email protected]